Accelerating transformative biomedical technologies

We combine cross-company talent and technology sharing with the infrastructure of a much larger organisation, giving TOGL companies and select collaborators priority access to advanced platforms, processes, and departments. This model enables fast, cost-efficient, and fully controlled development of products that address urgent, unmet global healthcare needs.

Each of our companies pursues its own priorities, yet we actively seek new partnerships, academic or commercial, that enhance our capabilities, biobanks, data repositories, and intellectual property.